The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B.

The clinical application of salvianolic acid B (Sal B), a potential therapeutic agent for cardiovascular diseases isolated from Salvia miltiorrhiza, is greatly restricted by its short half-life and low bioavailability. To improve therapeutic effects and prolong the systemic circulation time of Sal B, liposomes, composed of soybean phosphatidylcholine and cholesterol were prepared by reverse-phase evaporation method. In addition, polyethylene glycol 2000-disteroylphosphoethanolamine (PEG-DSPE 2000) was included to give steric barrier to liposomes. A central composite design was employed to optimize liposomal formulation with high encapsulation efficiency and small particle size. Physicochemical characteristics such as particle size, zeta potential, encapsulation efficiency and in vitro release were investigated. In vivo pharmacokinetic properties of Sal B in beagle dogs and the effect of PEG on the blood circulation time of Sal B-loaded liposomes were also evaluated. An optimized formulation with encapsulation efficiency of 73.68% and mean particle size of 136.6nm were developed. Encapsulation of Sal B into conventional and PEGylated liposomes could prolong the half-life of Sal B by 5.8- and 17.5-fold and enhance the AUC(0-t) of Sal B by 6.7- and 13.3-fold compared with free Sal B, respectively. Therefore, the use of PEGylated liposomes could prolong the circulation time in blood and longevity effect of liposomes on Sal B was increased by PEG.

[1]  T. Nakazawa,et al.  Metabolism of rosmarinic acid in rats. , 1998, Journal of natural products.

[2]  U. Vahlensieck,et al.  Metabolism of caffeic acid in the isolated perfused rat liver. , 1993, Planta medica.

[3]  Dennis E. Koppel,et al.  Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants , 1972 .

[4]  Zhong Zuo,et al.  Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use , 2005, Journal of clinical pharmacology.

[5]  T. Allen.  The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system , 1994 .

[6]  C. Nastruzzi,et al.  Liposomes Containing Distamycins: Preparation, Characterization and Antiproliferative Activity , 2004, Drug delivery.

[7]  N. Nakamura,et al.  Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat. , 2004, Planta medica.

[8]  T. Tsai,et al.  Determination and pharmacokinetic analysis of salvianolic acid B in rat blood and bile by microdialysis and liquid chromatography. , 2005, Journal of chromatography. A.

[9]  Lin Yuan,et al.  Effects of salvianolic acid B on proliferation, neurite outgrowth and differentiation of neural stem cells derived from the cerebral cortex of embryonic mice , 2010, Science China Life Sciences.

[10]  Yang Cheng,et al.  Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells. , 2010, Journal of ethnopharmacology.

[11]  Zhigang Lv,et al.  Salvianolic Acid B Inhibits ERK and p38 MAPK Signaling in TGF-β1-Stimulated Human Hepatic Stellate Cell Line (LX-2) via Distinct Pathways , 2011, Evidence-based complementary and alternative medicine : eCAM.

[12]  Zhirong Zhang,et al.  Enhanced oral bioavailability of salvianolic acid B by phospholipid complex loaded nanoparticles. , 2008, Die Pharmazie.

[13]  Ming-Shi Shiao,et al.  Bioavailability of salvianolic acid B in conscious and freely moving rats. , 2006, International journal of pharmaceutics.

[14]  B. Tan,et al.  Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats. , 2003, Life sciences.

[15]  G. Du,et al.  Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. , 2002, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[16]  Jun-song Li,et al.  Comparative pharmacokinetic and bioavailability studies of three salvianolic acids after the administration of Salviae miltiorrhizae alone or with synthetical borneol in rats. , 2011, Fitoterapia.

[17]  Xiao-ling Fang,et al.  Bioavailability of salvianolic acid B and effect on blood viscosities after oral administration of salvianolic acids in beagle dogs , 2009, Archives of pharmacal research.

[18]  Byung Mu Lee,et al.  Pharmacokinetics of Lithospermic Acid B Isolated from Salvia Miltiorrhiza in Rats , 2005, Journal of toxicology and environmental health. Part A.

[19]  L. Foo,et al.  Polyphenolics of Salvia--a review. , 2002, Phytochemistry.

[20]  C. Liu,et al.  Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. , 2002, World journal of gastroenterology.

[21]  N. Nakamura,et al.  Magnesium lithospermate B is excreted rapidly into rat bile mostly as methylated metabolites, which are potent antioxidants. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[22]  C. Rhodes,et al.  Preparation and characterization of liposomes as therapeutic delivery systems: a review. , 1995, Pharmaceutica acta Helvetiae.

[23]  Chu Mao-quan.  Study on the preparation of tanshinone proliposomes by spray drying method , 2002 .

[24]  Xiao Dong Chen,et al.  Optimization of ethanol-water extraction of lignans from flaxseed , 2007 .

[25]  Y. Siow,et al.  Inhibition of stress-activated protein kinase in the ischemic/reperfused heart: role of magnesium tanshinoate B in preventing apoptosis. , 2000, Biochemical pharmacology.

[26]  Sanjay K. Jain,et al.  Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells , 2007, Journal of drug targeting.

[27]  F. Szoka.  The future of liposomal drug delivery , 1990, Biotechnology and applied biochemistry.

[28]  G Blume,et al.  Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.

[29]  Gang-yi Liu,et al.  Pharmacokinetics of magnesium lithospermate B after intravenous administration in beagle dogs. , 2004, Acta pharmacologica Sinica.

[30]  Yun-Lian Lin,et al.  Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats , 2009 .

[31]  Xu Shen,et al.  Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling , 2010, BMC pharmacology.

[32]  T M Allen,et al.  Long circulating liposomes: past, present and future. , 1996, Biotechnology advances.

[33]  Pingliu,et al.  Clinical observation of salvianolic acid Bin treatment of liver fibrosis in chronic hepatitisB , 2002 .

[34]  Rui Wang,et al.  Salvianolic acid B protects human endothelial cells from oxidative stress damage: a possible protective role of glucose-regulated protein 78 induction. , 2009, Cardiovascular research.

[35]  Jean-Pierre Benoit,et al.  Physico-chemical stability of colloidal lipid particles. , 2003, Biomaterials.

[36]  T. Allen.  Long-circulating (sterically stabilized) liposomes for targeted drug delivery. , 1994, Trends in pharmacological sciences.

[37]  K. Edwards,et al.  Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Xiaoming Zhang,et al.  Effect of different preparation methods on physicochemical properties of salidroside liposomes. , 2007, Journal of agricultural and food chemistry.

[39]  F. DeEds,et al.  Urinary metabolites of caffeic and chlorogenic acids. , 1957, The Journal of biological chemistry.

[40]  G. Betageri,et al.  Factors affecting microencapsulation of drugs in liposomes. , 1995, Journal of microencapsulation.

[41]  Cheng-Hai Liu,et al.  Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-β1 signal transduction pathway in vivo and in vitro , 2010, BMC Cell Biology.

[42]  Yingjin Yuan,et al.  Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.